1037 [Dow Jones] STOCK CALL: Smith Barney keeps Buy rating on Cochlear (COH.AU) after U.S. rival Advanced Bionics gets another FDA warning letter; notes issue not major one, but adds may impact reputation. Also says early feedback from new COH implant "very positive." Adds Advanced Bionics also bringing out product upgrade in July, but says won't materially shift market shares. Keeps A$36.66 price target on COH vs latest A$31.35, off 1.4%. (RJN)
COH should finish in the black today.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$311.94 |
Change
0.480(0.15%) |
Mkt cap ! $20.39B | |||
| Open | High | Low | Value | Volume |
| $311.41 | $312.52 | $309.13 | $59.47M | 190.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $311.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $312.66 | 5 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
| COH (ASX) Chart |